ESTHMR إستثمر

GlaxoSmithKline S.A.E. BIOC

جلاكسو سميثكلاين

Health Care & PharmaceuticalsEgyptian Exchange

350.11 EGP

+8.86%

Close of Thu 1 Oct 2026

Market value
EGP 29.24bn
Highest and lowest close in a year
58.03 – 550.00
Shares traded in the session
1,080,723
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

GlaxoSmithKline S.A.E. is a Cairo-based pharmaceuticals company operating in the Pharmaceuticals, Biotechnology and Life Sciences sector. Established in January 1981 and incorporated on 14 January 1981, it has been listed on the EGX since October 1985. It is controlled by Glaxo Group Ltd, which holds 91.2%, with Qatar National Bank holding 5.89%. It holds 99.64% of Amoun Pharmaceutical Industries and 20.0% of Modern Pharma International.

Facts from Mubasher

Its record at the exchange

Between 2010 and 2026, the company accumulated 524 filings, peaking in 2022 with 45 filings. Its trading was suspended 20 times and resumed 18 times. Across 66 reported periods of financial results from 2013 to 2026, it reported 10 loss-making periods. Net results ranged from a peak net profit of 921 million EGP in 9M 2022 to a low of -131 million EGP in 9M 2015.

Its latest filings at the exchange

  1. ResultsGlaxoSmithKline (BIOC.CA) announces its consolidated 6-month financial results
  2. ResultsGlaxoSmithKline (BIOC.CA) announces its standalone 6-month financial results
  3. ResultsGlaxoSmithKline (BIOC.CA) announces its standalone 3-month financial results
  4. ResultsGlaxoSmithKline (BIOC.CA) announces its consolidated 3-month financial results
  5. ResultsGlaxoSmithKline (BIOC.CA) announces its standalone financial results for the financial year ended 31/12/2025
  6. ResultsGlaxoSmithKline (BIOC.CA) announces its consolidated financial results for the financial year ended 31/12/2025
  7. ResultsGlaxoSmithKline (BIOC.CA) announces its consolidated 9-month financial results
  8. ResultsGlaxoSmithKline (BIOC.CA) announces its standalone 9-month financial results

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

No insider trades in the company in the exchange bulletins we have read.

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 1 Oct 2026.